Epidemiological intricacies of respiratory pathogens: a single-center study on infection dynamics in Beijing, 2023–2024
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1581815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Wang Jie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Respiratory Tract Infections, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Following China’s post-COVID-19 reopening strategy, intermittent small-scale outbreaks of respiratory pathogen infections have been observed in the Beijing region. This single-center study aims to characterize the epidemiological features and co-detection patterns of respiratory pathogens in Beijing, providing a scientific basis for the prevention and control of respiratory infectious diseases.
Methods
We performed a retrospective analysis of 19,535 patients undergoing SARS-CoV-2 testing and 12,372 patients screened for six respiratory pathogens, including Mycoplasma pneumoniae (MP), respiratory syncytial virus (RSV), human rhinovirus (HRV), influenza A virus (IAV), adenovirus (ADV), and influenza B virus (IBV) at Peking University People’s Hospital from January 2023 to December 2024. Epidemiological data were systematically collected and analyzed.
Results
SARS-CoV-2 positivity rate maintained above 3% throughout the observation period. IAV demonstrated distinct seasonal peaks in March 2023 (41.9%, 52/124), November–December 2023 (24.5%, 119/485 to 21.9%, 208/950), and December 2024 (25.4%, 289/1136). Poly-epidemics of multiple pathogens emerged between October 2023 and April 2024. Pediatric populations showed highest prevalence of MP (21.4%, 158/740), co-detection (15%, 111/740) and ADV (12.7%, 94/740), while adults predominantly exhibited SARS-CoV-2 (35.1%, 674/1920), RSV (15.8%, 304/1920) and IAV (12.3%, 236/1920). Among 324 co-detection cases, MP (130 cases), HRV (117 cases), and IAV (111 cases) were most frequently involved, with MP + HRV (36 cases), MP + IAV (31 cases), and HRV + IAV (23 cases) being the predominant pairwise combinations.
Conclusion
Beijing experienced alternating waves of respiratory pathogen epidemics and co-detections during 2023–2024. IAV maintained characteristic winter–spring seasonality, while MP emerged as the predominant pathogen in co-detection events. Distinct pathogen profiles between pediatric and adult populations underscore the necessity for continuous surveillance and age-specific prevention strategies for respiratory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
- Department of Clinical Laboratory, Affiliated Hospital of Inner Mongolia Minzu University, Mongolia, China.
Zitieren
APA
Jie, W., Wenyan, H., Chang, L., Jinghong, F., Wenyi, L., Shanshan, L., & Ming, S. (2025). Epidemiological intricacies of respiratory pathogens: a single-center study on infection dynamics in Beijing, 2023–2024. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1581815
Vancouver
Jie W, Wenyan H, Chang L, Jinghong F, Wenyi L, Shanshan L, et al. Epidemiological intricacies of respiratory pathogens: a single-center study on infection dynamics in Beijing, 2023–2024. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1581815
BibTeX
@article{Jie2025,
author = {Jie, Wang and Wenyan, Huo and Chang, Liu and Jinghong, Feng and Wenyi, Li and Shanshan, Li and Ming, Su},
title = {Epidemiological intricacies of respiratory pathogens: a single-center study on infection dynamics in Beijing, 2023–2024},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1581815}
}
EUVIMED